IntegraDose Compounding Services LLC is recalling 281 syringes of Vasopressin (2 Unit/2 mL in 0.9% Sodium Chloride). This injectable medication is being recalled because it was found to be subpotent, meaning it contains less of the active drug than specified. The recall involves 2 mL syringes labeled with lot number 20230921VAS-2 and an expiration date of March 19, 2024.
A subpotent drug may fail to provide the intended therapeutic effect. For a medication like Vasopressin, this could result in inadequate blood pressure support or ineffective treatment of fluid balance disorders.
Quantity: 281 syringes; Manufactured in Minneapolis, MN.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.